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A B S T R A C T
CD44 is a cell adhesion molecule that functions in cell proliferation, differentiation, migration and angiogenesis,
as well as in signaling for cell survival. CD44 acts also as the main hyaluronan receptor. CD44 has been im-
plicated to have a role in carcinogenesis.
Aim of the study: In this study the expression of CD44 in mucoepidermoid carcinoma was detected and correlated
with the histopathological grade.
Material and methods: peroxidase-antiperoxidase immunohistochemical technique for the detection of CD44
expression in mucoepidermoid carcinoma.
Results: There was no statistically significant difference between the expression of CD44 in high and low grade
mucoepidermoid carcinoma. Yet, the pattern of expression varied in both.
Conclusion: CD44 pattern of expression correlates with mucoepidermoid carcinoma histopathological grade.
Correlates with increased proliferative activity and presumably increased cellular motility.
Summary: From this study it was deducted that over-expression of CD44 correlates with increased proliferative
activity and presumably increased cellular motility.
1. Introduction
Cell adhesion molecules (CAMs), were thought to function only in
attaching cells to the extracellular matrix components. Now however,
this concept has changed, they are now recognized as having broader
functions through their role in signal transduction [1]. CD44 is a CAM
that is involved in cell-cell and cell-matrix signaling and adhesion [2,3].
CD44 is a single-chain molecule that is made up of three main parts
extracellular, intracellular and transmembrane domains [4].
CD44 is associated with lipid rafts (glycolipid enriched membrane
microdomains, GEMs), through the transmembrane domain. This as-
sociation is cell type and cell activation state dependant [5]. The in-
tracellular part (cytoplasmic tail) is linked with the cytoskeleton via
ankyrin and ERM proteins and acts in signal transduction through its
association with the Src phosphokinases. The cytoplasmic tail binds
Merlin when the cell is in its' “quicent” state [5,6].
CD44 is expressed in normal basal epithelium of the skin and
mucous membrane and in normal glandular epithelium, as well as, in
tumors of these epithelial structures. CD44 is found in myoepithelium
of normal salivary glands which may argue in favor of the role of these
molecules in the regulation of growth and renewal under physiological
conditions [7,8]. Researchers, also suggest that the binding of CD44 to
HA is involved in cell guidance, as it was observed experimentally, that
cells establish lamellipodia directed towards HA application [9]. Ob-
servations also point to a role for CD44 in inflammation, through
phagocytosis and clearance of apoptotic cells and microbial pathogens
by macrophages [10].
Added to its role in inflammation, CD44 was also found to have an
important role in carcinogenesis under selective conditions [1,11].
Carcinogenesis involves abnormalities of cell adhesion, proliferation
and angiogenesis [12].
CD44 may take part in carcinogenesis through its role in signal
transduction which may be direct through binding to ligands or indirect
by acting as a co-receptor [13]. CD44 acts as a co-receptor by binding to
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HA and then forming complexes with HER2 and c-Src kinase which
triggers “cross-talk” between signaling pathways, during tumor devel-
opment [14,15]. HER2 oncogene expression correlates with poor
prognosis in many cancers [16].
At the same time, Cytoplasmic domains of CD44 have been shown to
be involved in the recruitment of Src kinases `oncogenic proteins' fa-
mily (Hck, Lyn, Fyn and Lck) in some tumors [17–19]. CD44 is also
associated with the Rho members of the Ras superfamily. The over-
expression of Rho GTPases is associated with poor patient outcome in
several tumors. Their activity allows the formation of lamellopodia
through the cleavage of CD44 and hence cellular motility [20,21].
CD44 cytoplasmic tail does not have an intrinsic receptor kinase or
phosphatase activity, of its own. Nevertheless, it still acts as a docking
site for growth factors [13].
Binding of HA to CD44 receptors, initiates extracellular clustering of
CD44, in migrating. The clustering of the CD44 molecule may result in
the activation of Ras which leads to tumor growth [13,19]. The cyto-
plasmic tail of CD44 binds to Ankyrin, which mediates HA dependant
cell adhesion and motility [1,22]. Between the transmembrane region
and the Ankyrin binding site on the cytoplasmic tail of CD44 lies a site
for binding the ERM proteins which is the same binding site for the
tumor suppressor protein Merlin (an ERM like protein) [23].
CD44-ERM association cross-links the CD44 molecule to the actin
cytoskeleton, which is vital for the maintaining cell shape and regula-
tion of cell movement [5]. In that sense, researchers suggest that CD44
can act as a metastases promoting factor on binding of the cytoplasmic
tail to ERM and as a tumor suppressor on binding to Merlin [24]by
negatively regulating CD44 function [25] (Table 1).
Merlin is activated in the hypophosphorylated state, it acts as a
tumor suppressor protein. Several theories were proposed as to the
cause of Merlin inactivation [6]. The first theory, anticipated that at
low cellular densities Merlin allows for cell proliferation while at high
cell densities it depresses proliferation due to the effect of contact in-
hibition between cells. This contact inhibition of growth is lost in
transformed cells (may be due to the presence of a HA coat enclosing
the cells or the messed up signals from the tumor cells) [23].
The second theory presented that CD44 and Merlin cause cell cycle
arrest, when the concentration of high molecular weight HA is elevated.
While, upon degradation of this HA, the tumor benefits in two ways.
The reduced concentrations of high-molecular-weight HA allows tumor
cells to escape from CD44-Merlin mediated cell-cycle arrest.
Simultaneously, the degradation products of HA, alter the tumor micro-
environment, like for example the upregulation of MMPs. MMPs in turn
cause the cleavage of the CD44, allowing for increased cell proliferation
[26]. CD44 and HA are interconnected, one allowing the cleavage of the
other [27,28]. The third theory for Merlin inactivation is through the
sequestration of growth factors via CD44, which inhibit Merlin de-
phosphorylation and its tumor suppressive, anti-proliferative activity
[6].
Ahrens, T., et al., 2001 [29] stated that cleavage of CD44 from the
cell surface is mediated by proteases and metalloproteinases. This di-
vides the CD44 molecule into fragments, one fragment remains in the
cell membrane and the other is soluble and is released from the cell
membrane (sol CD44). Further proteolysis of the retained part liberates
a CD44 intracellular domain fragment (ICD) [30]. The mobilization of
the CD44-ICD to the nucleus upregulate its own expression and other
molecules like integrin. Integrins in turn are involved in the regulation
of cell adhesion, proliferation and metastases [31].
The CD44 molecule has binding sites for growth factors and matrix
metalloproteinases (MMP). It has been observed that MMP binding to
CD44 resulted in degradation of collagen type IV thus mediating cel-
lular migration and activation of TGF-β, which caused neovasculiza-
tion. Activation of MMP was also dependant upon binding of HA to
CD44 [1].
Thus, through the interaction of CD44 with several molecules it
imparts features to the tumor cell that may allow it to proceed through
all steps of the metastasis [5]. Nevertheless, it should be noted that,
binding of HA to the CD44 does not always activate a signaling cascade
in the same manner, but this activation differs from cell type to cell type
[28].
Native high molecular weight HA is anti-angiogenic while, Low
molecular weight fragments of HA stimulate CD44-mediated angio-
geneis in-vitro and in-vivo [28,32]. Reports have led to the assumption
that, not only does HA and/or its degradation products induce angio-
genesis [33,34] but it may also be involved in CD44 cleavage that en-
hances tumor motility [13,33]. HA is a ubiquitous ECM component The
salivary glands like other tissues are made up of cells and extracellular
matrix [32,34].
Mucoepidermoid carcinoma (MEC) is a common malignant salivary
gland tumor [35,36]. MEC is classified either into low- and high-grade
types by some authors or into high, low and intermediate grades by
others. Prognosis varies according to the clinical stage, histological
grade and sufficiency of the performed surgery [35–37].
Histopathologically, low grade MEC (MEC-LG) exhibit cystic areas
containing mucinous material, as well as, numerous mucous cells. High
grade MEC (MEC-HG) appear to be less cystic and with a more in-
filtrative pattern of growth. In MEC-HG the cells are mainly of the in-
termediate or epidermoid types. These cells show pleomorphism and
increased mitotic activity. In the intermediate grade the intermediate
cells predominate [38]. Cytokines have been implicated where there is
stimulation of tumor growth, For example, TGF-β, is found consistently
with MEC-HG [39,40]. In this study the expression of CD44 in MEC was
detected and correlated with the histopathological grade.
2. Material and methods
2.1. Case selection
The material of this study consisted of 20 formalin fixed, paraffin
embedded specimens of MEC salivary gland tumors. All cases included
in the study were collected from the archives of the Pathology
Department, National Cancer Institute, Cairo University, Egypt. MEC
cases were further categorized into high grade and low grade according
to their histological features. The study also included two cases of
normal salivary gland tissue.
2.2. Histopathology
The sections were histologically reviewed using hematoxylin and
eosin (H&E) stain, used for routine pathological diagnosis, in order to




For the detection of CD44s antigen, a monoclonal mouse IG1, pre-
diluted antiCD44s antibody was used. The antibody was purchased
from Visionbiosystems Novocastra™ Laboratories, Ltd, United Kingdom.
These antibodies are designed for the specific localization of antigen in
formalin fixed paraffin embedded tissue sections. Peroxidase-anti-
peroxidase technique was performed for the immunohistochemical
Table 1
Quick review on Merlin and the ERM.
Merlin and ERM
Merlin and ERM are structurally related proteins. ERM proteins binds to actin and is
involved in cytoskeletal and membrane remodeling. These proteins localize to
the membrane ruffles and microvilli. Merlin acts as a tumor suppressor protein
[1].
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staining using the ready-to-use universal kit, Visionbiosystems
Novocastra ™ Detection System, Purchased from Visionbiosystems
Novocastra ™ laboratories,Ltd., United Kingdom.
2.3.2. IHC evaluation
For each MEC case, four fields at a 40× magnification, showing
highest immunopositivity were captured using a digital video camera
(C5060, Olympus, Japan), mounted on a light microscope (BX60,
Olympus, Japan). The captured images were digitally analyzed by the
computer, using image analysis software (Image J, 1.41a, NIH, USA).
Phase analysis was calculated automatically to give the area fraction
of the positive cells. The area fraction was given by the percentage of
immunopositive area per total microscopic field area. Finally, the area
fraction for each microscopic field was measured.
2.3.3. Assessment of the results
The collected data was tabulated using Microsoft Excel (Microsoft
Office, 2003). For all cases, the area fraction of immunopositivity for at
least 4 different microscopic fields was measured. The mean area
fraction for each case was then calculated and used for statistical ana-
lysis. Also, the hitopathological pattern of expression was carefully
evaluated and noted.
2.4. Statistical assessment
All MEC cases of this study were incorporated in the statistical
analysis. The data was tabulated using the Statistical Package for Social
Science (SPSS 15.0) Software. The statistical tests performed included
the independent sample T-test for comparison of means. This test was
done for the mean area fraction of immunopositivity to CD44s in MEC-
LG and MEC-HG. The results were considered significant when the P
value was ≤0.05.
Comparison between Mean area fractions of immunopositivity to
CD44s in MEC-LG and MEC-HG was performed using analysis of var-
iants test (ANOVA -for more than two groups-). Graphs were performed
using Microsoft power point Software (Microsoft Office, 2003).
3. Results
3.1. Light microscopic results
Immunopositivity appeared as brown staining in the cytoplasm or
on the plasma membrane or both. The lesions were considered positive
when at least one positive tumor cell was detected.
3.1.1. Normal salivary gland tissue
The two stained sections of normal salivary gland tissue showed
immunopositivity to CD44s in the cytoplasm and on the plasma mem-
brane of the acinar epithelial cells, the staining was most intense on the
basal and the lateral cell membranes in serous (Fig. 1) and mucous acini
(Fig. 2). Myoepithelial cells were immunopositive (Fig. 1). The cells
lining the ducts were immunonegative.
3.1.2. MEC
All lesions revealed immunopositivity to CD44s. In MEC-LG, some of
the cells lining the duct like structures were immunonegative, others
were immunopositive (Figs. 3 and 4). The neoplastic cells forming
masses in MEC-LG were mostly immunopositive. The positive reaction
was membranous in most of the cells with only few cells showing cy-
toplasmic reaction (Fig. 4). For MEC-HG, all neoplastic cells forming
masses exhibited cytoplasmic and membranous immunopositive reac-
tion (Figs. 5–7).
3.2. Image analysis and statistical results
The study showed that the mean area fraction of MEC-LG was
10.5375% and 14.9167% for MEC-HG. The mean area fraction of im-
munopositive cells in MEC-LG were fewer than the MEC-HG. (Table 3)
(Fig. 8).
Using the independent t-test for the comparison, it was found that
there was no significant difference between the mean area fraction of
immunopositivity to CD44s in the MEC- LG and MEC-HG, (p-
Table 2





Fig. 1. Photomicrograph of a normal salivary gland showing immunopositivity on the cell membrane of serous acini, also note the immunopositivity of myoepithelial
cells (arrows) (CD44s, orig. magx40).
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value=0.49). (Table 4).
4. Discussion
Several studies were performed to detect the expression of CD44 in
malignancy. Some researchers found that the increased expression does
correlate with increased grade of malignancy [1,3]. While, others found
that there was no change in CD44 expression between normal, benign
or malignant lesions [41]. In this study, we evaluated the expression of
CD44 in MEC as an example of a malignant salivary gland tumor and
correlated the expression of CD44 in its low and high grades.
Salivary gland tumors are rare, comprising less than 3% of all
neoplasms of the head and neck region. Reports from several parts of
the world have shown differences in the incidence of salivary gland
tumors [42]. Data collected from the pathology department, National
Cancer Institute, Cairo University, showed that MEC was the most
common malignant salivary gland tumor during the period from 2004
to 2016. This is why these tumors were used as material for this study.
The results of this study revealed that, in normal salivary glands,
CD44 expression was located in the acinar cells and the myoepithelial
cells of the ducts. The expression was found to be on the basal and
lateral cell membranes of the acinar cells. These results were consistent
with the results of Franchi et al. (2001) [43].
It was observed in this study that, the immunopositivity was rela-
tively higher-even though the difference was not significant-in MEC-HG
than MEC-LG. A finding that could be explained by the belief that,
CD44 may be up-regulated in high grade tumor cells, due to the ex-
pression of abnormal or amplified growth factor receptors, such as EGF,
TGF-beta and HER2 oncogene, which result in the up-regulation of
CD44, especially in the MEC-HG [39].
The histopathological pattern of CD44 expression was different
between both tumor grades in this study. In MEC-LG, the expression
Fig. 2. Photomicrograph of a normal salivary gland showing immunopositivity on the cell membrane of mucous acini (CD44s, orig. magx20).
Fig. 3. Photomicrograph of MEC-LG Showing, duct like structures. Most of the inner cells lining the ducts were immunonegative (A), while the outer ones were
immunopositive (B). Also, note the positive reaction was mostly membranous (CD44s, orig. mag. x20).
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was mostly membranous while the MEC-HG exhibited cytoplasmic ex-
pression as well. In the MEC-LG the luminal surface of the cells forming
the duct like structures were mostly immunonegative and the outer
layer showed immunopositivity. The absence of expression of CD44 on
the luminal surface of the cells is probably due to the absence of the
ligands of the CD44 molecule as CD44 functions in cell to cell and cell-
matrix adhesion.
The cytoplasmic expression of CD44 noted in MEC-HG could result
from the Proteolytic cleavage of CD44 resulting in the release of a CD44
intracellular domain fragment (ICD). The CD44-ICD translocates to the
nucleus and thus giving a positive reaction through out the cytoplasm.
Several studies proved that the presence of this ICD fragment correlates
with increased proliferation and metastases and hence the cytoplasmic
expression increases with increased grade of malignancy in salivary
gland tumors [25,31,32].
The tumors studied showed masses of epithelial cells in MEC-HG.
CD44 increases the chances of clustering of cells, this is in agreement
with Ponta et al., 2003 [1]. Sugahara et al., 2003, also stated that, the
over expression of CD44 by tumor cells enhances the homotypic ag-
gregates of tumor cells which in turn results in stabilizing receptors and
not allowing ligands that negatively regulate kinase activity to attach to
the receptors [33]. CD44-HA interactions result in cell matrix cross
bridging and hence mediating cell aggregation. Also, up-regulation of
CD44 expression on the cells forming masses may be due to the role of
CD44 in signal transduction participating in increased proliferation and
mass formation. This is through it's association with c-erbB2, c-Src and
Ras and by acting as a harboring site for growth factors [17,19,21].
Another explanation for the increased mass formation with in-
creased CD44 expression is through the inactivation of Merlin (a tumor
suppressor protein that is associated with CD44) causing loss of its
growth inhibitory function [25,26]. The inactivation of Merlin may be
through; loss of contact inhibition between cells, presence of low mo-
lecular weight HA and/or sequestration of growth factors via the CD44
molecule [27,29]. Besides its role in tumor growth and proliferation
CD44 may be involved in the enhancement of cell survival. The in-
creased cell survival may be due to the presence of a HA coat which
protects the cells from immune surveillance and thus allowing them to
survive longer [28,30].
Ligand binding to CD44, is not a passive task, but on the contrary, it
initiates a cascade of events through CD44 activation. When CD44 is
Fig. 4. Photomicrograph of MEC-LG Showing, duct like structures and epidermoid masses. In the masses some epidermoid cells were immunopositive (A) and others
were immunonegative (B). The immunopositive reaction was membranous in most of the epidermoid cells. (CD44s, orig. mag. x20).
Fig. 5. Photomicrograph of MEC-HG Showing, epidermoid cells forming masses. Note that, all epidermoid cells were immunopositive (CD44s,orig. mag. x20).
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activated it binds to more ligands like growth factors, MMP and ele-
ments of the cytoskeleton. Thus, the interaction of CD44 with its lig-
nands may well allow a tumor cell form metastases [13,16,19,21,32].
The presence of MMP in the tumor environment has a crucial role in
modulating CD44 function as a cell adhesion molecule. One assumption
is that, MMP cleaves CD44 molecule, so the increased expression de-
tected in this study may be due to, the accumulation of cleavage
products of the molecule between and with in cells as opposed to the
presence of the whole molecule so, in spite of the increased expression
there is loss rather than gain of adhesion [29–31]. Another assumption
is that, MMP bound to CD44 is protected from its inhibitors and thus is
allowed to cleave extra-cellular matrix components and consequently
allowing migration of tumor cells [1,30,31]. On top of that, MMP ac-
tivate angiogenic factors, e.g., the proform of TGF-B, leading to neo-
angiogenesis [1,5]. Hence, the higher expression of CD44 in high grade
MEC signifies increased cellular motility.
CD44 localization is an additional important factor to consider, not
just the mere increase in expression. Tzircotis et al., 2005 [17], Cher-
ukuri, et al., 2001 [18] and Bourguignon et al., 2001 [19]. Researchers
[5,25], have demonstrated before that the association of CD44 with
lipid rafts and/or the actin cytoskeleton, may affect lateral movement
of CD44 proteins on plasma membrane that are important in altering
cell to cell and cell matrix adhesion.
Fig. 6. Photomicrograph of MEC-HG, note immunopositivity in the cytoplasm and the plasma membrane. (CD44s,orig. mag. x20).
Fig. 7. Higher magnification of the previous photomicrograph of MEC-HG Showing, immunopositive epidermoid cells, the reaction was in the cytoplasm and the
plasma membrane. (CD44s,orig.mag. x40).
Table 3
Descriptive analysis of immunopositive mean area fraction with CD44 among
the studied cases.
Tumor Frequency Mean area fraction ± S.D
MEC –LG 8 10.538 4.3025
MEC –HG 12 14.917 4.696
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In many cancers an upregulation of CD44 expression is not always
associated with bad prognosis. On the contrary, its upregulation in
some tumors is associated with a better prognsis. Not just that, but in
many cases different research groups analyzing the same type of tumor
came to contradicting conclusions as regards to CD44 expression and
disease prognosis [8]. These differences in results may possibly be due
to differences in methodologies. Regardless of the reason behind these
differences they must be resolved before applying anti-CD44 targeted
therapy for human cancers safely.
5. Conclusions
CD44 pattern of expression correlates with MEC histopathological
grade.
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